Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aniel Sanchez

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Molecular and Cellular Biochemistry|July 8, 2011
CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical researchSilvio E Perea, Idania Baladron, Yanelda Garcia, et al.
Cell Biology and Toxicology|March 23, 2019
Clinical protein science in translational medicine targeting malignant melanomaJeovanis Gil, Lazaro Hiram Betancourt, Indira Pla, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Predicting immune checkpoint therapy response in three independent metastatic melanoma cohortsLeticia Szadai, Aron Bartha, Indira Pla Parada, et al.
International Journal of Dermatology|December 25, 2024
Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma SubtypesIndira Pla, Botond L Szabolcs, Petra Nikolett Péter, et al.
Frontiers in Oncology|July 17, 2024
Predicting immune checkpoint therapy response in three independent metastatic melanoma cohortsLeticia Szadai, Aron Bartha, Indira Pla Parada, et al.
Clinical and Translational Medicine|July 20, 2024
Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanomaNatália Pinto de Almeida, Ágnes Judit Jánosi, Runyu Hong, et al.
Clinical and Translational Medicine|July 29, 2021
The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptomeLazaro Hiram Betancourt, Jeovanis Gil, Aniel Sanchez, et al.
Clinical and Translational Medicine|July 29, 2021
The human melanoma proteome atlas-Defining the molecular pathologyLazaro Hiram Betancourt, Jeovanis Gil, Yonghyo Kim, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Molecular and Cellular Biochemistry|July 8, 2011
CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical researchSilvio E Perea, Idania Baladron, Yanelda Garcia, et al.
Cell Biology and Toxicology|March 23, 2019
Clinical protein science in translational medicine targeting malignant melanomaJeovanis Gil, Lazaro Hiram Betancourt, Indira Pla, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Predicting immune checkpoint therapy response in three independent metastatic melanoma cohortsLeticia Szadai, Aron Bartha, Indira Pla Parada, et al.
International Journal of Dermatology|December 25, 2024
Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma SubtypesIndira Pla, Botond L Szabolcs, Petra Nikolett Péter, et al.
Frontiers in Oncology|July 17, 2024
Predicting immune checkpoint therapy response in three independent metastatic melanoma cohortsLeticia Szadai, Aron Bartha, Indira Pla Parada, et al.
Clinical and Translational Medicine|July 20, 2024
Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanomaNatália Pinto de Almeida, Ágnes Judit Jánosi, Runyu Hong, et al.
Clinical and Translational Medicine|July 29, 2021
The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptomeLazaro Hiram Betancourt, Jeovanis Gil, Aniel Sanchez, et al.
Clinical and Translational Medicine|July 29, 2021
The human melanoma proteome atlas-Defining the molecular pathologyLazaro Hiram Betancourt, Jeovanis Gil, Yonghyo Kim, et al.
Pageof 6